Advertisement
Document › Details
Faron Pharmaceuticals Oy. (3/1/17). "Press Release: Results of Placing and Subscription and Issue of Equity. Successful over-subscribed fundraising of £5.0 million through a Placing and Subscription [Not for United States, Australia, Canada, Japan, et al
Original document
accessed by [iito] on 2017-03-08
Record changed: 2023-06-05 |
Advertisement
More documents for Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON)
- [1] Faron Pharmaceuticals Oy. (1/4/21). "Press Release: Faron to Present at H.C. Wainwright BioConnect". Turku....
- [2] Faron Pharmaceuticals Oy. (2/5/18). "Press Release: Faron Establishes Second Traumakine Manufacturing Site". Turku....
- [3] Faron Pharmaceuticals Oy. (1/29/18). "Press Release: FDA Grants Fast Track Designation to Faron for Traumakine". Turku....
- [4] Faron Pharmaceuticals Oy. (2/28/17). "Press Release: Proposed Placing and Subscription to Raise Up to £5.0 Million [Not for United States, Australia, Canada, Japan, et al.]". Turku....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top